Filing Details
- Accession Number:
- 0001562180-15-000802
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-29 18:24:28
- Reporting Period:
- 2015-09-28
- Filing Date:
- 2015-09-29
- Accepted Time:
- 2015-09-29 18:24:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597553 | Sage Therapeutics Inc. | SAGE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612859 | Stephen Kanes | C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-09-28 | 21,000 | $0.45 | 52,948 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-09-28 | 6,000 | $46.42 | 46,948 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-09-28 | 21,000 | $0.00 | 21,000 | $0.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 133,100 | 2023-07-23 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- This transaction was executed in multiple trades at prices ranging from $46.00 USD to $46.92 USD. The price reported above reflects the weighted average sale price.
- 25% 1 year cliff then evenly for the remaining 36 months beginning on 18-Jul-2013
Billionaire Hedge Funds
